Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acute prostatitis].

F Bruyère1, G Cariou, J-P Boiteux

  • 1CHU Bretonneau, 2 boulevard Tonnellé, 37044 Tours cedex, France. f.bruyere@chu-tours.fr

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|June 17, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short CIAFU recommendations on the screening and management of asymptomatic bacteriuria in immunocompromised patients.

The French journal of urology·2025
Same author

What's new in the diagnosis and treatment of human brucellosis?

Infectious diseases now·2025
Same author

FIRE Stones: impact of forced diuresis on the residual fragment rate after flexible ureteroscopy for destruction of kidney stones with laser-protocol for a randomized controlled two-parallel group multicenter trial with blinding evaluation.

Trials·2024
Same author

A proposed mathematical model to help preoperative planning between RIRS and MiniPerc for renal stones between 10 and 20 mm using holmium:Yag laser (Cyber Ho): the stone management according to size-hardness (SMASH) score.

Urolithiasis·2024
Same author

[Infections and male infertility].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) - 2023 SPILF.

Infectious diseases now·2023
Same journal

["Connected device for monitoring patients treated by prostatectomy: Implementation and qualitative assessment"].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

[Role of nurses specializing in oncology to support the care journey for patients with penile cancer].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

[Pre- and post-prostatectomy rehabilitation by the certified nurse-urologist pair (REHAB): Feasibility study].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

[Genitourinary complications after pelvic radiotherapy: Diagnosis and management].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
Same journal

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same journal

[Male contraception].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
See all related articles

Febrile urinary infections in men are typically prostatitis. Treatment involves identifying complications and draining residual urine, followed by 3-6 weeks of antibiotics like fluoroquinolones or cephalosporins.

Area of Science:

  • Urology
  • Infectious Diseases

Context:

  • Febrile urinary tract infections (UTIs) in men are often indicative of prostatitis.
  • Clinical presentation necessitates investigation for complicating factors.

Purpose:

  • To define the diagnostic and therapeutic approach for prostatitis in febrile men.
  • To outline essential investigations and treatment protocols.

Summary:

  • Prostatitis diagnosis in febrile men requires evaluating for complicating factors and post-void residual urine.
  • Management includes draining residual urine and initiating antibiotic therapy.
  • Recommended antibiotics include fluoroquinolones or cephalosporins for 3 to 6 weeks.

Impact:

  • Establishes a clear management pathway for prostatitis.

Related Experiment Videos

  • Aims to improve patient outcomes by ensuring timely and appropriate treatment.
  • Highlights the importance of addressing residual urine in UTI management.